Clinical practice guidelines for peritoneal dialysis in patients with chronic kidney disease stage 5 (CKD 5)


E.V. Shutov, O.N. Kotenko

About the Autors

  1. Абдрашитова Г.Т., Серпик В.Г., Ягудина Р.И. Фармакоэкономический анализ оказания медицинской помощи больным с хронической болезнью почек, нуждающимся в проведении заместительной почечной терапии методами перитонеального диализа и гемодиализа в условиях Российского здравоохранения. Фармакоэкономика: теория и практика. 2015;3:(3). [Abdrashitova G.T., Serpik V.G., Yagudina R.I. Pharmacoeconomic analysis of the provision of medical care to patients with chronic kidney disease, in need of replacement renal therapy using peritoneal dialysis and hemodialysis in the Russian health care setting. Farmakoekonomika: teoriya i praktika. 2015; 3: (3). (In Russ.)].

  2. Приказ Министерства здравоохранения и социального развития РФ от 18 января 2012 г. N 17н «Об утверждении Порядка оказания медицинской помощи взрослому населению по профилю “нефрология”». [Order of the Ministry of Health and Social Development of the Russian Federation dated January 18, 2012 N 17n “On approval of the procedure for rendering medical care to adults in the nephrology profile”. (In Russ.)].

  3. Sorkin M.I., Diaz-Buxo J.A. Physiology of Peritoneal Dialysis .In:Handbook of Dialysis Ed. Daugirdas J.T., Ing T.S.1994:245–261.

  4. Шутов Е.В. Перитонеальный диализ. М. 2000. [Shutov E.V. Peritoneal dialysis. M. 2000. (In Russ.)].

  5. Levey A.S., Stevens L.A., Schmid C.H. et al. A new equation to estimate glomerular filtration rate. Ann.Intern.Med 2009;150:604–612.

  6. Cho Y., Johnson D.W., Craig J.C., et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst. Rev. 2014;3:CD007554.

  7. Cice G., Di Benedetto A,D’Isa S., et al. Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 2010;56:1701–1708.

  8. Blake P.G., Bargman J.M., et al. Clinical practice guidelines and recommendations on peritoneal dialysis adequacy 2011. Perit. Dial. Int. 2011;31:218–239.

  9. Bredie S.J., Bosch F.H., Demacker P.N., et al. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit. Dial. Int. 2001;21:275–281.

  10. Wolfson M., Piraino B., Hamburger R.J., Morton A.R. on behalf of the Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icod extrininperitoneal dialysis. Am. J. Kidney Dis. 2002;40:1055–1065.

  11. Li P.K., Culleton B.F., Ariza A., et al. on behalf of the IMPENDIA and EDEN Study Groups. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J. Am. Soc.Nephrol. 2013;24:1889–900.

  12. Himmele R., Jensen L., Fenn D., Ho C.H., Sawin D.A., Diaz-Buxo J.A. A new neutral pH low GDP peritoneal dialysis fluid. Perit. Dial. Int. 2012;32:444–452.

  13. Johnson D.W., Brown F.G., Clarke M. et al. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Perit. Dial. Int. 2012;32(5):497–506.

  14. European Best Practice Guidelines for Peritoneal Dialysis. Nephrol. Dial. Transplant. 2005;20.

  15. Mujais S., Nolph K., Gokal R. et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit. Dial. Int. 2000;20(4):S5–21.

  16. Peritoneal Dialysis-Related Infections Recommendations: 2010 Update. Perit.Dial.Int. 2010;30:393.

  17. Национальные клинические рекомендации по лечению пациентов с хронической болезнью почек 5-й стадии (ХБП-5) перитонеальным диализом, 2016. [National clinical guidelines for the treatment of patients with chronic kidney disease 5th stage (CKD-5) peritoneal dialysis, 2016. (In Russ.)].

  18. Twardowski Z., Nolph K. Khanna R Peritoneal equilibration test. Perit. Dial. Bull. 1987;7.

Бионика Медиа